Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Thomas E. Renau"'
Autor:
Aesop Cho, Nadeem Iqbal, Bonnie Kuo, Karen Lolans, Deidre Madsen, William J. Watkins, Negar Garizi, Rémy C. Lemoine, Renata Jankowska, Vickie Wong, Maria Ludwikow, Rajeshwar Singh, John Barnard, Lee Chong, Uma Oza, Michael N. Dudley, Thomas E. Renau, Olga Lomovskaya
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 14:5133-5137
Structure-activity relationships of a novel series of fungal efflux pump inhibitors with respect to potentiation of the activity of fluconazole against strains of Candida albicans and Candida glabrata over-expressing ABC-type efflux pumps are systema
Autor:
Yakira Landaverry, Nicole Williams, Suzanne Chamberland, Thomas E. Renau, Vrushali Tembe, Deidre Madsen, Roger Leger, Rose Yen, Keith Huie, Michael N. Dudley, Jason Z. Zhang, David A. Griffith, Renee Litman, William J. Watkins
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:4241-4244
Following the optimization of diamine-containing efflux pump inhibitors with respect to in vitro potentiation activity, in vivo stability and acute toxicity, we addressed the question of how to control the pharmacokinetic properties of the series. Up
Autor:
Kumi Yoshida, Haruko Kawato, Yoshida Kenichi, William J. Watkins, Ving J. Lee, Yohei Ishida, Tsuyoshi Otani, Thomas E. Renau, Yoshihiro Yokomizo, Hiroko Ishida, Kazuki Hoshino, Masami Ohtsuka, Toshiharu Ohta, Yuichi Kurosaka, Kiyoshi Nakayama
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:4205-4208
Problems of low solubility, high serum protein binding, and lack of efficacy in vivo in first generation MexAB-OprM specific efflux pump inhibitors were addressed. Through the use of pharmacophore modelling, the key structural elements for pump inhib
Autor:
Yoshida Kenichi, Shigeru Hosono, William J. Watkins, Haruko Kawato, Yoshihiro Yokomizo, Kiyoshi Nakayama, Kumi Yoshida, Toshiharu Ohta, Kazuki Hoshino, Roger Leger, Masami Ohtsuka, Ving J. Lee, Jason Z. Zhang, Yohei Ishida, Thomas E. Renau, Hiroko Ishida
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:4201-4204
The identification of a series of compounds that specifically inhibit efflux by the MexAB-OprM pump system in Pseudomonas aeruginosa is described. Synthesis and in vitro structure-activity relationships (SARs) are outlined. Early leads lacked activit
Publikováno v:
Synthetic Communications. 33:3285-3289
5-Bromopyridine-2-carbonitrile was efficiently synthesized in two steps from 2,5-dibromopyridine with an overall yield of 75%.
Autor:
William J. Watkins, Thomas E. Renau
Publikováno v:
Burger's Medicinal Chemistry and Drug Discovery. :881-918
Autor:
Thomas E. Renau, M. Reza Nassiri, Leroy B. Townsend, Jennie G. Jacobson, Dominica G. Sweier, Julie M. Breitenbach, John C. Drach
Publikováno v:
Antimicrobial Agents and Chemotherapy. 43:1888-1894
Based upon a prior study which evaluated a series of nonnucleoside pyrrolo[2,3- d ]pyrimidines as inhibitors of human cytomegalovirus (HCMV), we have selected three active analogs for detailed study. In an HCMV plaque-reduction assay, compounds 828,
Autor:
Stephen J. Gracheck, John M. Domagala, Robert C. Reynolds, Gregory E. Roland, Julie A. Dever, Martin A. Shapiro, M R Jacobs, Thomas E. Renau, E. T. Joannides, Joseph P. Sanchez, Jeffrey W. Gage
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:2363-2368
A series of quinolones with substitutions at the 8 position has been prepared as part of a study to examine the relationship between structural modifications at this position and activity against mycobacteria. The compounds were prepared by procedure
Publikováno v:
Journal of Heterocyclic Chemistry. 33:1407-1411
A series of 8-bromo-4-oxo-3-quinolinecarboxylic acids was prepared via the borate ester, 8. The key intermediate in the synthesis of the final products 10a-10d was 3-bromo-2,4,5-trifluorobenzoic acid (3), conveniently prepared in two steps from the k
Autor:
Martin A. Shapiro, Stephen J. Gracheck, Julie A. Dever, Thomas E. Renau, John M. Domagala, Joseph P. Sanchez, Jeffrey W. Gage
Publikováno v:
Journal of Medicinal Chemistry. 39:729-735
The re-emergence of tuberculosis infections which are resistant to conventional drug therapy has demonstrated the need for alternative chemotherapy against Mycobacterium tuberculosis. As part of a study to optimize the quinolone antibacterials agains